Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
- Published In:
- Circulation research, 91(5), 434-40 (2002)
- Authors:
- Szokodi, István, Tavi, Pasi, Földes, Gábor, Voutilainen-Myllylä, Sari, Ilves, Mika, Tokola, Heikki, Pikkarainen, Sampsa, Piuhola, Jarkko, Rysä, Jaana, Tóth, Miklós, Ruskoaho, Heikki
- Database ID:
- RPEP-00776
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00776APA
Szokodi, István; Tavi, Pasi; Földes, Gábor; Voutilainen-Myllylä, Sari; Ilves, Mika; Tokola, Heikki; Pikkarainen, Sampsa; Piuhola, Jarkko; Rysä, Jaana; Tóth, Miklós; Ruskoaho, Heikki. (2002). Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.. Circulation research, 91(5), 434-40.
MLA
Szokodi, István, et al. "Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.." Circulation research, 2002.
RethinkPeptides
RethinkPeptides Research Database. "Apelin, the novel endogenous ligand of the orphan receptor A..." RPEP-00776. Retrieved from https://rethinkpeptides.com/research/szokodi-2002-apelin-the-novel-endogenous
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.